Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CLEMENCE・LABORATORY, Inc. is a Tokyo-based beauty and medical-related company located in Shibuya, Japan. Founded in 2019, it is a subsidiary of Trenders, Inc., a company listed on the Tokyo Stock Exchange Growth Market. Its business covers cosmetics planning, development, and sales, as well as the planning of beauty clinic and aesthetic medicine treatment programs. Its e-commerce-related operations mainly include its in-house skincare brand HERRAS® and Doctors Picks OnlineShop, an online store selling doctor-selected skincare products, cosmetics, and supplements curated by physicians and beauty professionals.
In terms of platform/service type, this is not an open marketplace-style e-commerce platform. It is closer to a brand company combined with a vertical beauty retail channel. The source text explicitly mentions mail-order sales and wholesale sales to beauty clinics, so its business model includes both DTC retail and B2B wholesale partnerships. In terms of product selection, the key selling point of Doctors Picks is that products are “carefully selected by physicians and beauty professionals,” with a focus on doctor-recommended skincare and supplements. It is suitable for consumers who care about ingredients, professional endorsement, and products related to aesthetic medicine. On the supply chain side, the company is directly involved in cosmetics planning, development, and sales, giving it certain brand-operation capabilities.
The collected text does not disclose product prices, membership systems, commissions, platform onboarding fees, or wholesale terms. It also does not specify logistics carriers, delivery areas, shipping timeframes, or return and exchange policies. Payment methods are not mentioned either, so it is not possible to determine whether credit cards, convenience store payments, e-wallets, or overseas payments are supported. From the perspective of access or purchasing from China, the current text provides no information on website accessibility, cross-border shipping, or payment support, so china_access can only be assessed as unknown.
Its strengths are that the company entity, representative, address, business scope, and parent company information are disclosed relatively completely. In addition, the founder has more than 12 years of experience as a beauty and aesthetic medicine journalist, giving the brand positioning a professional content background. Its business connects both consumer e-commerce and beauty clinic channels, making it fairly targeted for vertical beauty and doctor-recommended skincare scenarios. The downside is that the official website content is mainly a company introduction, while key e-commerce operational information is missing, including pricing, logistics, after-sales support, payment, cross-border services, and platform onboarding rules. This makes it difficult to directly assess the purchasing experience or the entry requirements for seller partnerships.
It is more suitable for consumers in Japan looking for skincare, doctor-developed cosmetics, and supplements selected by doctors or beauty experts. It may also suit beauty clinics interested in cosmetics wholesale or treatment program planning partnerships. For Chinese users, it is advisable to first confirm whether the official website can be accessed directly, whether overseas shipping is supported, and which payment methods are available. If purchasing is not possible, alternatives include Japanese local beauty e-commerce sites, official brand online stores, or other specialist e-commerce platforms for doctor-recommended skincare.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on clemencelaboratory.com official site.
clemencelaboratory.com is an Japan E-commerce provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach clemencelaboratory.com directly.